QCG
SPPI

Quadrant Capital Group’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Quadrant Capital Group’s Portfolio SPPI Stock Details SPPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-354
Closed – – 2754
2021
Q4 		$0 Buy
354
+53
+18% +$95 ﹤0.01% 2755
2021
Q3 		$1K Sell
301
-1,995
-87% -$5.45K ﹤0.01% 2438
2021
Q2 		$9K Hold
2,296
– – ﹤0.01% 1647
2021
Q1 		$7K Hold
2,296
– – ﹤0.01% 1684
2020
Q4 		$8K Sell
2,296
-38
-2% -$156 ﹤0.01% 1531
2020
Q3 		$10K Buy
2,334
+38
+2% +$144 ﹤0.01% 1253
2020
Q2 		$8K Buy
2,296
+2,103
+1,090% +$6.13K ﹤0.01% 1460
2020
Q1 		$0 Buy
+193
New +$528 ﹤0.01% 2310
2018
Q2 		– Sell
-42
Closed – – 2230
2018
Q1 		$0 Buy
+42
New +$832 ﹤0.01% 2238

Other funds holding SPPI

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $195M AUM 51.17% 1-Year Est. Return

Quadrant Capital Group's SPPI Position: Q1 2022 in Review

Quadrant Capital Group sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q1 2022, closing a stake of 354 shares.

Quadrant Capital Group first reported a position in SPPI in Q1 2018 and held it in 9 quarters. The position peaked at $10K in Q3 2020. 101 funds tracked by Wall St. Rank hold SPPI as of Q1 2022.

  • Quadrant Capital Group reported no remaining Spectrum Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
  • Quadrant Capital Group sold 354 Spectrum Pharmaceuticals Inc shares in Q1 2022.
  • Quadrant Capital Group first reported a position in Spectrum Pharmaceuticals Inc in Q1 2018 and held it in 9 quarters.
  • Quadrant Capital Group's Spectrum Pharmaceuticals Inc position peaked at $10K in Q3 2020.
  • 101 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q1 2022.

Based on Quadrant Capital Group's 13F filing for Q1 2022, filed 6 May 2022.